Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial
about
Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial
description
scientific article published on 11 November 2011
@en
wetenschappelijk artikel
@nl
name
Four-week neoadjuvant intensit ...... s: a validation phase II trial
@en
Four-week neoadjuvant intensit ...... s: a validation phase II trial
@nl
type
label
Four-week neoadjuvant intensit ...... s: a validation phase II trial
@en
Four-week neoadjuvant intensit ...... s: a validation phase II trial
@nl
prefLabel
Four-week neoadjuvant intensit ...... s: a validation phase II trial
@en
Four-week neoadjuvant intensit ...... s: a validation phase II trial
@nl
P2093
P1476
Four-week neoadjuvant intensit ...... s: a validation phase II trial
@en
P2093
Ana Chopitea
Javier Rodríguez
Jesús García-Foncillas
Jesús Javier Sola
Jorge Nuñez
Jose Carlos Subtil
Jose Luis Hernández
Juan A Díaz-González
Leire Arbea
Luis Isaac Ramos
P304
P356
10.1016/J.IJROBP.2011.06.2008
P577
2011-11-11T00:00:00Z